Blocks insurance delays on long-term prescriptions

File SB1258 ("Blocks insurance delays on long-term prescriptions") is before the Illinois Legislature and has not been decided. Latest step (March 27, 2026): Rule 3-9(a) / Re-referred to Assignments.

Illinois file SB1258, before the Illinois Legislature. Still to be decided as of 2026-03-27.

What it does

No more monthly approval delays for stable medications If you've been on the same prescription drug for 6 or more consecutive months, your insurer must fill refills without requiring prior authorization, eliminating waiting periods that can delay or interrupt treatment.

The bigger picture

Guaranteed access to HIV prevention and specialty drugs Insurers cannot require prior authorization for insulin, HIV prevention/treatment drugs (Truvada, Descovy, Apretude), hepatitis C treatment (Harvoni), estrogen, or progesterone—protecting patients with chronic conditions from coverage denials on FDA-approved therapies.

What to watch

Narrow scope; does not cover newly prescribed medications The bill only protects drugs you've been on for 6+ months, so patients starting new medications or switching treatments still face prior authorization requirements, and insurers retain authority to deny off-formulary non-preferred drugs in initial prescriptions.

Official summary

Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.

Read the official record for SB1258

See everything up for a vote · This week in Illinois · See what we have filed with the clerk